Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

TARS

Kedudukan dalam Saham #4590
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Harga Saham
$71.12
Modal Pasaran
$3.33B
Perubahan (1 hari)
2.33%
Perubahan (1 tahun)
-0.10%
Negara
US
Perdagangan Tarsus Pharmaceuticals, Inc. (TARS)

Kategori

Healthcare
Bilangan saham terbitan bagi Tarsus Pharmaceuticals, Inc. (TARS)
Bilangan saham terbitan setakat June 2026: 43.39M
Menurut laporan kewangan terkini dan harga saham Tarsus Pharmaceuticals, Inc., bilangan saham terbitan semasa ialah 43.39M. Pada akhir December 2023, syarikat mempunyai 29.38M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Tarsus Pharmaceuticals, Inc. (TARS) dari 2018 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 43.39M 15.39%
2024 37.60M 27.98%
2023 29.38M 19.35%
2022 24.62M 19.78%
2021 20.55M 1.14%
2020 20.32M 4.17%
2019 19.51M 355.26%
2018 4.29M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 485.11%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 812.58%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 1,003.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 43.31%
NL